Target intelligence / Profile preview

Immunoglobulin kappa variable 2D-29 (IGKV2D-29)

Target
IGKV2D-29
Molecular classification
Immunoglobulin variable domain, Immunoglobulin light chain
01

Overview

Immunoglobulin kappa variable 2D-29 (IGKV2D-29) encodes the variable region of the kappa light chain of immunoglobulins (antibodies)[1][2][3][5]. This variable region is critical for the diversity of antibody antigen-binding through V(D)J recombination and somatic hypermutation, contributing to the adaptive immune response[3][5]. IGKV2D-29 is a component of the immunoglobulin gene family and plays an essential role in the recognition of foreign antigens by B cells[3][5]. The gene exhibits marked polymorphism and allele distribution that varies among human populations, potentially influencing susceptibility to certain infections such as Haemophilus influenzae type b[4]. There is no evidence indicating that IGKV2D-29 itself is a direct therapeutic or druggable target, receptor, enzyme, or transporter; rather, it is a genetic element contributing to antibody diversity[3][4][5].

Other names
A2AIGKV2D29A2C
02

Biological functions

Antigen recognitionImmune response
03

Disease associations

Other (associated with variability in immune response, especially to infection)

Beyond the preview

Go deeper on Immunoglobulin kappa variable 2D-29 (IGKV2D-29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 2D-29 (IGKV2D-29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call